BlackRock, Inc. 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BlackRock, Inc. BLK | 5,345,114 8.000% | 1,427,625 (+36.44%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BlackRock, Inc. BLK | 3,917,489 7.300% | 641,319 (+19.58%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BlackRock, Inc. BLK | 3,276,170 6.900% | 1,162,975 (+55.03%) | Filing |